Table 4.

Laboratory detection of hematopoiesis in indications patients treated with rhEPO.

Observation time		Anemia caused by renal failure	P	Anemia caused by chemotherapy for non-bone marrow malignant tumors	P	Perioperative erythrocyte mobilization	P
MCV	Before	89.74 ± 6.11	<0.05	89.39 ± 7.88	<0.05	89.29 ± 2.49	<0.05
	After	90.11 ± 5.88		89.98 ± 7.31		89.87 ± 6.67
RDW	Before	14.01 ± 1.82	<0.05	15.44 ± 2.80	<0.05	15.04 ± 2.49	<0.05
	After	14.43 ± 2.01		15.91 ± 3.01		15.39 ± 2.56
MCHC	Before	331.9 ± 13.8	<0.05	331.2 ± 18.25	>0.05	333.5 ± 14.7	>0.05
	After	332 ± 13.25		331.9 ± 14.9		333.5 ± 13.7
Reticulocyte percentage	Before	2.28 ± 1.54	<0.05	2.25 ± 2.15	<0.05	2.21 ± 1.79	>0.05
	After	2.74 ± 1.65		2.44 ± 2.07		2.35 ± 1.93